DexCom, Inc. vs Marriott International Inc — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Marriott International Inc trades at $349.88 (market cap $91.14B). The key difference: Marriott International Inc is far larger — about 2.7× DexCom, Inc.'s market cap, and Marriott International Inc pays a 0.84% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | MAR | |
|---|---|---|
Market Cap | $33.79B | $91.14B |
Sector | Health | Consumer Cyclical |
52-Week High | $89.53 | $402.54 |
52-Week Low | $54.84 | $259.04 |
Enterprise Value | $33.24B | $108.45B |
Dividend Yield | — | 0.84% |
Trailing returns across standard periods
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →